In our experiments, we have shown that anti-EGFR mAbs and checkpoint inhibitors alone or in combination do not trigger autophagy in mutant KRAS and MSI-H CRC cell line, HCT116. The gene discussed is EGFR; the disease is colorectal carcinoma.